These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 25081749)
1. Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma. Tsai JH; Lin YL; Cheng YC; Chen CC; Lin LI; Tseng LH; Cheng ML; Liau JY; Jeng YM Mod Pathol; 2015 Feb; 28(2):268-78. PubMed ID: 25081749 [TBL] [Abstract][Full Text] [Related]
2. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability. Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058 [TBL] [Abstract][Full Text] [Related]
3. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Walsh MD; Clendenning M; Williamson E; Pearson SA; Walters RJ; Nagler B; Packenas D; Win AK; Hopper JL; Jenkins MA; Haydon AM; Rosty C; English DR; Giles GG; McGuckin MA; Young JP; Buchanan DD Mod Pathol; 2013 Dec; 26(12):1642-56. PubMed ID: 23807779 [TBL] [Abstract][Full Text] [Related]
4. Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway. Bae JM; Kim JH; Rhee YY; Cho NY; Kim TY; Kang GH World J Gastroenterol; 2015 Sep; 21(33):9749-57. PubMed ID: 26361422 [TBL] [Abstract][Full Text] [Related]
5. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504 [TBL] [Abstract][Full Text] [Related]
6. Annexin A10 is a marker for the serrated pathway of colorectal carcinoma. Sajanti SA; Väyrynen JP; Sirniö P; Klintrup K; Mäkelä J; Tuomisto A; Mäkinen MJ Virchows Arch; 2015 Jan; 466(1):5-12. PubMed ID: 25395067 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study. Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818 [TBL] [Abstract][Full Text] [Related]
8. Gastric-type expression signature in serrated pathway-associated colorectal tumors. Kim JH; Kim KJ; Rhee YY; Bae JM; Cho NY; Lee HS; Kang GH Hum Pathol; 2015 May; 46(5):643-56. PubMed ID: 25704805 [TBL] [Abstract][Full Text] [Related]
9. Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis. Tsai JH; Liau JY; Lin YL; Lin LI; Cheng YC; Cheng ML; Jeng YM Mod Pathol; 2014 Oct; 27(10):1375-85. PubMed ID: 24603588 [TBL] [Abstract][Full Text] [Related]
10. Serrated pathway in colorectal carcinogenesis. Yamane L; Scapulatempo-Neto C; Reis RM; Guimarães DP World J Gastroenterol; 2014 Mar; 20(10):2634-40. PubMed ID: 24627599 [TBL] [Abstract][Full Text] [Related]
11. Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway. Aoki H; Yamamoto E; Yamano HO; Sugai T; Kimura T; Tanaka Y; Matsushita HO; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Harada T; Sudo G; Eizuka M; Yorozu A; Kitajima H; Niinuma T; Kai M; Nojima M; Suzuki H; Nakase H Dig Dis Sci; 2018 Jul; 63(7):1920-1928. PubMed ID: 29546645 [TBL] [Abstract][Full Text] [Related]
12. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Kim JH; Bae JM; Cho NY; Kang GH Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry for annexin A10 can distinguish sporadic from Lynch syndrome-associated microsatellite-unstable colorectal carcinoma. Pai RK; Shadrach BL; Carver P; Heald B; Moline J; Church J; Kalady MF; Burke CA; Plesec TP; Lai KK; Gonzalo DH; Pai RK Am J Surg Pathol; 2014 Apr; 38(4):518-25. PubMed ID: 24625416 [TBL] [Abstract][Full Text] [Related]
15. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum. Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095 [TBL] [Abstract][Full Text] [Related]
16. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential. Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272 [TBL] [Abstract][Full Text] [Related]
17. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180 [TBL] [Abstract][Full Text] [Related]
18. Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway. Bae JM; Kim JH; Kang GH Arch Pathol Lab Med; 2016 May; 140(5):406-12. PubMed ID: 27128298 [TBL] [Abstract][Full Text] [Related]
19. CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway. Rhee YY; Kim KJ; Kang GH Gut Liver; 2017 Jan; 11(1):38-46. PubMed ID: 27885175 [TBL] [Abstract][Full Text] [Related]
20. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas. García-Solano J; García-Solano ME; Torres-Moreno D; Carbonell P; Trujillo-Santos J; Pérez-Guillermo M; Conesa-Zamora P Cell Oncol (Dordr); 2016 Jun; 39(3):243-52. PubMed ID: 26832730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]